Cannabinoid CB1 antagonists possess antiparkinsonian efficacy only in rats with very severe nigral lesion in experimental parkinsonism

Emilio Fernández‐Espejo, Isabel Caraballo, Fernando Rodrı́guez de Fonseca, Fadwa El Banoua, Belén Ferrer, Juan A. Flores, Beatriz Galán-Rodríguez

Neurobiology of Disease · 2005 · 102 citations · 40 references

DOIFull text

Open access

Concepts

References

40